Fiscal year 2026 EPS guidance raised -- New projected range of $8.55 to $9.05, with assumptions of no rate cuts, an 18% to 22 ...

Q4 2025 Earnings Call January 30, 2026 3:00 AM ESTCompany ParticipantsSophie Arnius - Head of Investor RelationsRickard Gustafson ...

Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

Discusses Backlog, Pipeline, and Revenue Recognition Strategy Across AI Infrastructure and Data Center Programs ...

Legend Power Systems Inc. (TSXV: LPS) (OTCQB: LPSIF) ("Legend Power" or the "Company"), a global leader in commercial electrical system ...

Pathward Financial, Inc. (NASDAQ:CASH) Q1 2026 Earnings Call Transcript January 22, 2026 Pathward Financial, Inc. beats ...

FY 2025 Preliminary Unaudited Total Revenue of Approximately $510--511 Million Meets or Exceeds Prior Guidance Previously Provided FY 2025 Adjusted EBITDA (1) and Adjusted Net Income (2) Guidance ...

VANCOUVER, BC / ACCESS Newswire / January 22, 2026 / Avino Silver & Gold Mines Ltd. (TSX:ASM)(NYSE American:ASM)(GV6:FSE) a long-standing silver producer in Mexico, reports full year 2025 production r ...

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today ...

Kuya Silver to Host Live Webinar Thursday, January 22th to Discuss Recent Financing and Q4 Operational Results All references ...

An estimated 3 million Americans have an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis. But ...

Detailed price information for Entrada Therapeutics Inc (TRDA-Q) from The Globe and Mail including charting and trades.